Literature DB >> 27702869

Electrophysiological features and catheter ablation of symptomatic frequent premature atrial contractions.

Xinhua Wang1, Zheng Li1, Jialiang Mao1, Ben He1.   

Abstract

AIMS: Frequent premature atrial contractions (PACs) are associated with increased risk of atrial fibrillation (AF), stroke, and death. This study aimed to explore the electrophysiological features of PACs with and without inducing AF and to evaluate the effectiveness of catheter ablation for PACs. METHODS AND
RESULTS: Thirty-five consecutive patients with symptomatic, frequent, and drug-refractory PACs in the absence of AF (group A) and 35 patients with PACs-induced AF (group B) were enrolled. Coupling intervals (CoIs) of PACs were compared. Premature atrial contractions were mapped by the point-by-point and/or circular mapping technique. Focal ablation or pulmonary vein/superior vena cava isolation was applied as appropriate. A total of 35 ectopic foci were identified in group A. The majority of them were at pulmonary vein (PV) (n = 7), crista terminalis (n = 6), and para-Hisian area (n = 6). In group B, ectopic foci were in left-sided PVs in 21 patients, in right-sided PVs in 13 patients, and in SVC in 1 patient. There was significant difference in CoIs of PACs triggering AF and those from PVs and non-PV areas but without causing AF (362.8 ± 23.0 ms vs. 470.6 ± 60.1 ms vs. 515.6 ± 77.2 ms, P< 0.001). Premature atrial contractions were abolished in 32 of 35 patients from group A and in all patients from group B. At the end of follow-up, 29 patients in group A and 28 patients in group B were free of recurrence (off antiarrhythmic drugs) after the initial ablation (P =0.97).
CONCLUSIONS: Frequent PACs in the absence of AF were characterized as having their predilection sites and longer CoIs than those inducing AF. Catheter ablation was effective to eliminate symptomatic, frequent, and drug-refractory PACs. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation; Coupling interval; Focal ablation; Premature atrial contraction; Pulmonary vein isolation

Mesh:

Substances:

Year:  2017        PMID: 27702869     DOI: 10.1093/europace/euw152

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  5 in total

Review 1.  Mapping of atrial fibrillation: strategies to understand an enigmatic arrhythmia.

Authors:  Isabel Deisenhofer
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-09-13

2.  Electrophysiological characteristics and catheter ablation of symptomatic focal premature atrial contractions originating from pulmonary veins and non-pulmonary veins.

Authors:  Xingfu Huang; Yanjia Chen; Junhui Xiao; Hongxin Zhao; Yizhen Chen; Shenrong Liu; Liwei He; Zheng Huang; Haobin Zhou; Dingli Xu; Jian Peng
Journal:  Clin Cardiol       Date:  2018-01-25       Impact factor: 2.882

3.  Electrophysiological characteristics of non-pulmonary vein triggers excluding origins from the superior vena cava and left atrial posterior wall: Lessons from the self-reference mapping technique.

Authors:  Yasuharu Matsunaga-Lee; Yasuyuki Egami; Sen Matsumoto; Nobutaka Masunaga; Kohei Ukita; Akito Kawamura; Hitoshi Nakamura; Yutaka Matsuhiro; Koji Yasumoto; Masaki Tsuda; Naotaka Okamoto; Masamichi Yano; Yuzuru Takano; Yasushi Sakata; Masami Nishino; Jun Tanouchi
Journal:  PLoS One       Date:  2022-04-06       Impact factor: 3.240

4.  Mapping and Ablation of Isolated Frequent Symptomatic Premature Atrial Contractions in Patients With Structurally Normal Heart.

Authors:  Bo He; Yi Li; Weiping Huang; Wenxi Yu; Fang Zhao; Xiaoyan Wu; Shuyuan Yao; Sunny S Po; Zhibing Lu
Journal:  Front Cardiovasc Med       Date:  2022-04-12

5.  Association between P wave polarity in atrial premature complexes and cardiovascular events in a community-dwelling population.

Authors:  Tomoyuki Kabutoya; Yasushi Imai; Shizukiyo Ishikawa; Kazuomi Kario
Journal:  BMJ Open       Date:  2020-11-04       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.